Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-6-23
|
pubmed:abstractText |
Cytomegalovirus (CMV), the most significant infectious cause of morbidity following renal transplantation, may be a greater problem for children than for adults due to their relative lack of experience with this virus. Therefore, we prospectively gave Gammagard as prophylaxis to CMV-negative children who received CMV-positive allografts and compared the results to our experience with similar high-risk recipients transplanted prior to our use of intravenous immunoglobulin G (IvIgG). Symptomatic CMV disease developed in 17% of the IvIgG recipients as compared with 71% of the untreated patients (p = 0.01). The CMV infections that did occur in IvIgG recipients developed significantly later than in untreated children (median time of onset after transplantation 2.60 vs. 1.35 months; p < 0.05) and generally were less severe, although 1 IvIgG recipient died despite prophylaxis. IvIgG administration did not affect the frequency of rejection or graft or patient survival. We conclude that IvIgG administration to high-risk pediatric renal transplant recipients may protect against posttransplantation CMV disease and may lessen the severity of infections that do develop in patients who receive it.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-8095
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
146-52
|
pubmed:dateRevised |
2007-2-14
|
pubmed:meshHeading |
pubmed-meshheading:9096445-Child,
pubmed-meshheading:9096445-Cytomegalovirus Infections,
pubmed-meshheading:9096445-Female,
pubmed-meshheading:9096445-Graft Rejection,
pubmed-meshheading:9096445-Humans,
pubmed-meshheading:9096445-Immunoglobulins, Intravenous,
pubmed-meshheading:9096445-Immunosuppression,
pubmed-meshheading:9096445-Kidney Transplantation,
pubmed-meshheading:9096445-Male,
pubmed-meshheading:9096445-Morbidity,
pubmed-meshheading:9096445-Postoperative Complications,
pubmed-meshheading:9096445-Prospective Studies,
pubmed-meshheading:9096445-Risk Factors
|
pubmed:year |
1997
|
pubmed:articleTitle |
Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric renal transplant recipients.
|
pubmed:affiliation |
Department of Pediatrics, St. Christopher's Hospital for Children, Temple University of School of Medicine, Philadelphia, Pa., USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|